| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |